Patients' Access to Treatments Act of 2015
Official title: To amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in … Show full official titleShow less
Official title: To amend title XXVII of the Public Health Service Act to limit co-payment, coinsurance, or other cost-sharing requirements applicable to prescription drugs in a specialty drug tier to the dollar amount (or its equivalent) of such requirements applicable to prescription drugs in a non-preferred brand drug tier, and for other purposes.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Referred to the Subcommittee on Health.
Patients' Access to Treatments Act of 2015
Amends the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure. Prohibits such a health plan from imposing higher cost-sharing requirements, including co-payment and co-insurance, for specialty drugs than for other prescription drugs in a non-preferred brand drug tier. Applies the non-preferred brand drug tier for which beneficiary cost-sharing is lowest, if a formulary used by the health plan contains more than one non-preferred brand drug tier.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 1600: Patients' Access to Treatments Act of 2015. 114th Congress. Open America. https://openamerica.io/bill/114-HR-1600/
"H.R. 1600: Patients' Access to Treatments Act of 2015." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-1600/.
H.R. 1600, 114th Cong. (2026), https://openamerica.io/bill/114-HR-1600/.
[H.R. 1600: Patients' Access to Treatments Act of 2015](https://openamerica.io/bill/114-HR-1600/)